Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 462-469

  Sionov, Ronit Vogt ^a   Naor, David ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; LYMPHOMA CELL; METASTASIS POTENTIAL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; CELL ADHESION; CELL DIVISION; FEMALE; HYALURONIC ACID; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOID TISSUE; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0031009021     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<462::AID-IJC26>3.0.CO;2-G     Document Type: Article

References (24)

1. BARTOLAZZI, A., PEACH, R., ARUFFO, A. and STAMENKOVIC, I., Interaction between CD44 and hyaluromate is directly implicated in the regulation of tumor development. J. exp. Med., 180, 53-66 (1994).
2. CULTY, M., MIYAKE, K., KINCADE, P.W., SILORSKI, E., BUTCHER, E.C. and UNDERHILL, C.J., The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol., 111, 2765-2774 (1990).
3. DE BELDER, A.N. and WIK, K.O., Preparation and properties of fluoresceinlabelled hyaluronate. Carbohydr. Res., 44, 251-257 (1975).
4. DRIESSENS, M.H.E,. STROEKEN, P.J.M., RODRIGUEZ ERENA, N.F., VAN DER VALK, M.A., VAN RUTHOVEN, E.A.M. and Roos, E., Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J. Cell Biol., 131, 1849-1855 (1995).
5. Fox, S.B., FAWCETT, J., JACKSON, D.G., COLLINS, I., GATTER, K.C., HARRIS, A.L., GEARING, A. and SIMMONS, D.L., Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546 (1994).
6. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUß-MANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
7. GUO, Y., MA, J., WANG, J., CHE, X., NARULA, J., BIGBY, M., WU, M. and SY, M.-S., Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res., 54, 1561-1565 (1994).
8. KNUDSON, C.B. and KNUDSON, W., Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J., 7, 1233-1241 (1993).
9. LESLEY, J., HYMAN, R. and KINCADE, P.W., CD44 and its interaction with the extracellular matrix. Adv. Immunol., 54, 271-335 (1993).
10. LESLEY, J., ENGLISH, N., PERSCHL, A., GREGOROFF, J. and HYMAN, R., Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. exp. Med., 182, 431-437 (1995).
11. MIYASAKA, M., Cancer metastasis and adhesion molecules. Clin. Orthop., 312, 10-18 (1995).
12. NAOR, D., VOGT SIONOV, R. and ISH-SHALOM, D., CD44: structure, function and association with the malignant process. Adv. Cancer Res., 71, 241-319 (1997).
13. SEITER, S., ARCH, R., REBER, S., KOMITOWSKI, D., HOFMANN, M., PONTA, H., HERRLICH, P., MATZKU, S. and ZÖLLER, M., Prevention of tumor metastasis formation by anti-variant CD44. J. exp. Med., 177, 443-455 (1993).
14. SHERMAN, L., SLEEMAN, J., HERRLICH, P. and PONTA, H., Hyaluronate receptors: key players in growth, differentiation, migration, and tumor progression. Curr. Opin. Cell Biol., 6, 726-733 (1994).
15. SLEEMAS, J.P., ARMING, S., MOLL, J.F., HEKELE, A., RUDY, W., SHERMAN, L.S., KREIL, G., PONTA, H. and HERRLICH, P., Hyaluronate-independent metastatic behaviour of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res., 56, 3134-3141 (1996).
16. SY, M.-S., Guo, Y.-J. and STAMENKOVIC, I., Distinct effects of two CD44 isoforms on tumor growth in vivo. J. exp. Med., 174, 859-866 (1991).
17. SY, M.-S., Guo, Y.-J. and STAMENKOVIC, I., Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. exp. Med., 176, 623-627 (1992).
18. THOMAS, L., BYERS, H.R., VINK, J. and STAMENKOVIC, I., CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol., 118, 971-977 (1992).
19. VAN MUIJEN, G.N., DANEN, E.H., VEERKAMP, J.H., RUITER, D.J., LESLEY, J. and VAN DEN HEUVEL, L.P., Glycoconjugate profile and CD44 expression on human melanoma cell lines with different metastatic capacity. Int. J. Cancer, 61, 241-248 (1995).
20. WEST, D.C., HAMPSON, I.N., ARNOLD, F. and KUMAR, S., Angiogenesis induced by degradation products of hyaluronic acid. Science, 228, 1324-1326 (1985).
21. WU, L., KINCADE, P.W. and SHORTMAN, K., The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol. Lett. 38, 69-75 (1993).
22. ZAHALKA, M.A., OKON, E. and NAOR, D., Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). J. Immunol., 150, 4466-1477 (1993).
23. ZAHALKA, M.A., OKON, E., GOSSLAR, U., HOLZMANN, B. and NAOR, D., Lymph node (but not spleen) invasion by murine lymphoma is both CD44 and hyaluronate-dependent. J. Immunol. 154, 5345-5355 (1995).
24. ZHANG, L., UNDERHILL, C.B. and CHEN, L., Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55, 428-433 (1995).